Detection by in situ hybridization and phenotypic characterization of cells expressing IL-6 mRNA in human stimulated blood.
Open Access
- 15 February 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 144 (4) , 1317-1322
- https://doi.org/10.4049/jimmunol.144.4.1317
Abstract
IL-6 has manifold biologic functions in immune and inflammatory responses and is produced by a variety type of cells. In this work, we used the whole blood culture to identify the cells expressing IL-6 gene/protein after various stimulation. When the whole blood was incubated with LPS or Con A, much IL-6 activity, measured by the growth promoting assay using a murine IL-6-dependent hybridoma clone, was detected in the plasma as early as 4 h of culture and continued to increase with time, reaching a plateau around 12 h. Immunocytochemical analysis with anti-rIL-6 antiserum revealed that a proportion of mononuclear cells (MNC) contained intracytoplasmic IL-6 in LPS- or Con A-stimulated blood. Northern blot analysis for MNC from the blood stimulated with these stimuli showed that their transcripts for IL-6 peaked at 4 h, then rapidly declined and was undetectable after 24 h of stimulation. In situ hybridization technique with radiolabeled antisense RNA probe for IL-6 demonstrated that a fraction of MNC from LPS- as well as Con A-stimulated blood expressed IL-6 mRNA. With the combined use of in situ hybridization and immunofluorescence by corresponding mAb, it was confirmed that IL-6 mRNA expressing cells in stimulated blood were exclusively monocytes. In the whole blood culture, it was shown that expression of IL-6 mRNA by monocytes was inhibited by dexamethasone, but not by cyclosporin A. These results suggest that monocytes are the major cells expressing IL-6 gene/protein in the circulation after exposure to external stimuli.This publication has 25 references indexed in Scilit:
- Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of mouse acute phase proteins.The Journal of Immunology, 1988
- ELEVATED LEVELS OF THE 26K HUMAN HYBRIDOMA GROWTH-FACTOR (INTERLEUKIN-6) IN CEREBROSPINAL-FLUID OF PATIENTS WITH ACUTE INFECTION OF THE CENTRAL NERVOUS-SYSTEM1988
- Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA.Proceedings of the National Academy of Sciences, 1988
- Monocyte-Derived Human B-Cell Growth Factor Identified as Interferon-β 2 (BSF-2, IL-6)Science, 1988
- Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms.Journal of Clinical Investigation, 1988
- Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.Proceedings of the National Academy of Sciences, 1987
- Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production.Proceedings of the National Academy of Sciences, 1987
- Production of hybridoma growth factor by human monocytesEuropean Journal of Immunology, 1987
- Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A.The Journal of Experimental Medicine, 1984
- Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.The Journal of Immunology, 1983